31 December 2003
Brain Death Associated Ischemia/Reperfusion Injury
Johann Pratschke, Stefan Tullius, Peter NeuhausAnn Transplant 2004; 9(1): 78-80 :: ID: 8011
Abstract
I/R is an important non-immunological, antigen independent factor influencing graft outcome. In addition to its non-specific effects it potentiates graft immunogenicity and increases host alloresponsiveness. Originally considered an event surrounding organ procurement, preservation and revascularization, it has recently been associated with donor conditions such as brain death and the non-heart-beating donor. Occurring early in the transplant process, it initiates a cascade of molecular and cellular events including the release of proinflammatory mediators and attraction of various cell types infiltrating the tissues. As a consequence, acute and chronic changes develop which influence structure and function of the organ which may contribute to reduced graft survival. Eventually, attentuation of I/R by strategies interfering with the different processes promoted by this insult may constitute a means to improve both short and long-term graft outcome.
In Press
Original article
Fundamental Strategies and Technical Perspectives in Bile Duct Anastomosis for Living Donor Liver Transplan...Ann Transplant In Press; DOI: 10.12659/AOT.953761
Clinical Research
Retrospective Study of Implementation and Outcomes of a Non-Cryopreserved Autologous Hematopoietic Stem Cel...Ann Transplant In Press; DOI: 10.12659/AOT.954230
Clinical Research
Prognostic Prediction in Living Donor Liver Transplantation Recipients With Complete Pathological Response ...Ann Transplant In Press; DOI: 10.12659/AOT.954574
Most Viewed Current Articles
24 Aug 2021 : Review article 21,978
Normothermic Machine Perfusion (NMP) of the Liver – Current Status and Future PerspectivesDOI :10.12659/AOT.931664
Ann Transplant 2021; 26:e931664
29 Dec 2021 : Original article 18,247
Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...DOI :10.12659/AOT.933588
Ann Transplant 2021; 26:e933588
22 Nov 2022 : Original article 16,856
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988
05 Apr 2022 : Original article 16,762
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604






